2014
DOI: 10.1002/jbt.21604
|View full text |Cite
|
Sign up to set email alerts
|

Protective Effects of Pterostilbene against Acetaminophen‐Induced Hepatotoxicity in Rats

Abstract: The present study was undertaken to evaluate the protective effect of pterostilbene against acetaminophen-induced hepatotoxicity. Silymarin was used as a standard hepatoprotective agent. A single dose of acetaminophen (800 mg/kg i.p.), injected to male rats, caused significant increases in serum levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, total cholesterol, triglycerides, tumor necrosis factor alpha, and hepatic contents of malondialdehyde, nitric oxide, cas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
31
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 49 publications
(51 reference statements)
2
31
1
Order By: Relevance
“…In addition, it shows efficacy against multiple diseases including ischemia-reperfusion damage, inflammation, and tumors. In vivo studies showed the effect of pterostilbene in reducing xanthine oxidase expression and improving ischemic injury of renal, testicular, muscular, ovarian, spinal cord, and brain tissues (Chen et al, 2015;El-Sayed et al, 2015). Hence, the results of this study were consistent with previous studies.…”
Section: Discussionsupporting
confidence: 90%
“…In addition, it shows efficacy against multiple diseases including ischemia-reperfusion damage, inflammation, and tumors. In vivo studies showed the effect of pterostilbene in reducing xanthine oxidase expression and improving ischemic injury of renal, testicular, muscular, ovarian, spinal cord, and brain tissues (Chen et al, 2015;El-Sayed et al, 2015). Hence, the results of this study were consistent with previous studies.…”
Section: Discussionsupporting
confidence: 90%
“…NO is a well-established marker of inflammation, and inhibition of its production can be a useful therapeutic strategy in inflammatory diseases [10, 34, 35]. Additionally, other inflammatory mediators, such as TNF- α , IL-1 β , and IL-6, are associated with the severity of hepatic injury [8, 36, 37].…”
Section: Discussionmentioning
confidence: 99%
“…The elevated levels of liver enzymes such as aspartate and ALT, AST, ALP, and total serum bilirubin found in CCl 4 induced liver injuries are reduced significantly by its use of silymarin both in animal and clinical studies. 24 Administration of aqueous extracts of E. alba showed significant hepatoprotective activity at 250 mg/kg and 500 mg/kg, which were comparable to the standard control silymarin at 50 mg/kg. The hepatoprotective effects were more pronounced with a higher dose of 500 mg/kg of aqueous extract of E. alba.…”
Section: Discussionmentioning
confidence: 85%